BMS-986278, an Oral Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist, for Patients With Idiopathic Pulmonary Fibrosis: Results From a Phase 2 Randomized Trial

Autor:	T.J. Corte, V. Cottin, M.K. Glassberg, M. Kreuter, T. Ogura, T. Suda, J.G. Goldin, E. Berkowitz, B. Elpers, S. Kim, G.S. Tirucherai, H. Watanabe, A. Fischer, T.M. Maher
Rok vydání:	2023
Zdroj:	B17. EMERGING DATA ON DISEASE AND SYMPTOM BASED THERAPEUTICS FOR PATIENTS WITH IPF.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8bb256b7f60370395ba794adc177d376 https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2785 Zobrazit plný text záznamu